Loading...

CTMX CYTOMX THERAPEUTICS INC Capital Structure Changes 8-K Filing

CYTM

CTMX

CYTOMX THERAPEUTICS INC

(CTMX)

2024 8-K

Financial Results

Clinical Trial Update

Financial Statements

Equity Offerings

Equity Offerings

Data Announcement

Financial Results

Management Change

Workforce Reduction

Q3 Financial Results

Financial Results

Appointment of CFO

Amendment to Certificate of...

Other Special Situation

Financial Results

Appointment of Director and...

Financial Results

Financial Results

Transition Agreement with A...

Financial Results

Equity Offerings

Financial Results

Financial Results Announcement

Liquidity Concern at Silico...

Restatement of Financial St...

Collaboration Agreement

External Links:

CytomX Therapeutics, Inc. filed an Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 150,000,000 to 300,000,000 shares.

AI Assistant

CYTOMX THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.